BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hallet J, Davis LE, Mahar AL, Isenberg-grzeda E, Bubis LD, Myrehaug S, Zhao H, Beyfuss K, Moody L, Law CHL, Coburn NG. Symptom Burden at the End of Life for Neuroendocrine Tumors: An Analysis of 2579 Prospectively Collected Patient-Reported Outcomes. Ann Surg Oncol 2019;26:2711-21. [DOI: 10.1245/s10434-019-07441-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hallet J, Coburn NG. ASO Author Reflections: Supporting Neuroendocrine Tumor Patients at the End of Life by Understanding Symptom Trajectories. Ann Surg Oncol 2019;26:847-8. [PMID: 31773515 DOI: 10.1245/s10434-019-07951-2] [Reference Citation Analysis]
2 Scandurra C, Modica R, Maldonato NM, Dolce P, Dipietrangelo GG, Centello R, Di Vito V, Bottiglieri F, de Cicco F, Giannetta E, Isidori AM, Lenzi A, Muzii B, Faggiano A, Colao A. Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience. J Clin Endocrinol Metab 2021;106:e316-27. [PMID: 33084861 DOI: 10.1210/clinem/dgaa760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]